Pfizer, Inc., recently announced ASPIRE  (Advancing Science through Pfizer Investigator- Research Exchange) Hemophilia 2013, a competitive research grants program open to US-based investigators. The primary objectives of the program are to support:

 

·         Basic science, translational and clinical research through competitive grants that advance medical knowledge in the pathogenesis and treatment of hemophilia.

·         Academic research and career development of promising young and established scientists.

 

The application deadline is May 20, 2013. Awardees will be notified in early June 2013 and officially announced at the XXIVth Congress of the International Society on Thrombosis & Haemostasis (ISTH) June 29-July 4 in Amsterdam, The Netherlands. Learn more about The ASPIRE Research Awards

 

Source: Pfizer, Inc., January 2013